Encision Inc. | Cash Flow

Fiscal year is April-March. All values USD Thousands.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
1,781.70
1,382.70
880.20
729.30
335.60
236.10
Depreciation, Depletion & Amortization
499.10
382.10
318.70
224.90
202.90
182.10
Other Funds
1,216.40
202.60
242.20
266.20
24.30
71.50
Funds from Operations
66.20
798.10
319.30
770.70
562.70
17.50
Changes in Working Capital
177.40
634.70
153.50
793.50
143.30
144.70
Net Operating Cash Flow
111.20
1,432.80
165.80
22.90
419.40
127.20
Capital Expenditures
458.40
62.20
98.50
133.20
100.00
Net Investing Cash Flow
458.40
62.20
98.50
133.20
100.00
Issuance/Reduction of Debt, Net
-
64.00
323.50
112.40
275.10
Net Financing Cash Flow
1,910.60
64.00
323.50
112.40
275.10
Net Change in Cash
1,563.40
1,430.90
59.20
222.70
44.40
Free Cash Flow
310.70
1,462.50
243.00
82.50
362.90
Change in Capital Stock
1,910.60
-
-
-
-

About Encision

View Profile
Address
6797 Winchester Circle
Boulder Colorado 80301
United States
Employees -
Website http://www.encision.com
Updated 07/08/2019
Encision, Inc. is a medical device company. The firm is engaged in the designing, developing and manufacturing of patented surgical instruments in the United States. Its patented Active Electrode Monitoring technology provides surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures while preventing stray electrosurgical energy that can cause complications and even death.